Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.440
+0.007 (0.49%)
At close: Sep 18, 2026, 4:00 PM EDT
1.440
0.00 (0.01%)
After-hours: Sep 18, 2026, 6:39 PM EDT
Pulmatrix Employees
Pulmatrix had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,014,500
Market Cap
5.26M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | -20 | -90.91% | 2 | 0 |
| Dec 31, 2023 | 22 | -7 | -24.14% | 22 | 0 |
| Dec 31, 2022 | 29 | 4 | 16.00% | 28 | 1 |
| Dec 31, 2021 | 25 | 3 | 13.64% | 24 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| NuCana | 12 |
| Dermata Therapeutics | 9 |
| Lexaria Bioscience | 7 |
| Ernexa Therapeutics | 7 |
| Can-Fite BioPharma | 5 |
| Kairos Pharma | 4 |
PULM News
- 5 weeks ago - Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - PRNewsWire
- 5 weeks ago - Pulmatrix Earnings release: Q2 2026 - Filings
- 5 weeks ago - Pulmatrix Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Pulmatrix Registration statement: Registration filing - Filings
- 3 months ago - Pulmatrix Registration statement: Registration filing - Filings
- 3 months ago - Pulmatrix files to sell 490,910 shares of common stock for holders - TheFly
- 4 months ago - Pulmatrix Announces First Quarter 2026 Financial Results - PRNewsWire
- 4 months ago - Pulmatrix Quarterly report: Q1 2026 - Filings